At 23:00, May 7, 2021, Beijing time, the World Health Organization held a press conference. Director-General Tan Desai announced that the new crown inactivated vaccine developed by Sinopharm Beijing Co., Ltd. will be included in its emergency use list. Tan Desai said that this is the sixth safe, effective and high-quality vaccine certified by the World Health Organization. It will expand the scope of vaccines that can be purchased under the New Coronary Pneumonia Vaccine Implementation Plan (COVAX), allowing regulatory authorities of various countries to be more confident to accelerate their own approval process to import the vaccine and vaccinate.

Previously, the State Food and Drug Administration and the World Health Organization conducted many consultations to clearly cooperate on matters related to the supervision of the new crown vaccine.